Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/09/2014WO2014164658A1 Methods of inhibiting leukotriene a4 hydrolase
10/09/2014WO2014164617A1 Cosmetic use of napthoic acid derivatives
10/09/2014WO2014164596A1 Bet bromodomain inhibitors and therapeutic methods using the same
10/09/2014WO2014164558A1 Pyridinyl and fused pyridinyl triazolone derivatives
10/09/2014WO2014164543A1 Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
10/09/2014WO2014164526A1 Oxamazin antibiotics
10/09/2014WO2014164467A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014164428A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014164409A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014164395A1 Combination anti-estrogen receptor cancer therapy using muc1 peptides and chemotherapeutics
10/09/2014WO2014164348A2 Modified caspase polypeptides and uses thereof
10/09/2014WO2014164286A1 Dual sglt1/sglt2 inhibitors
10/09/2014WO2014164285A2 Use of levocetirizine and montelukast in the treatment of vasculitis
10/09/2014WO2014164253A1 Heterologous untranslated regions for mrna
10/09/2014WO2014164200A1 Tyrosinase inhibitors
10/09/2014WO2014164195A1 Tyrosinase inhibitors
10/09/2014WO2014164021A1 Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
10/09/2014WO2014163656A1 Maintenance of platelet inhibition during antiplatelet therapy
10/09/2014WO2014163643A1 Gga and gga derivatives compositions thereof and methods for treating neurodegenerative diseases including paralysis including them
10/09/2014WO2014163520A1 Preparation for treating proctological, urological and gynaecological diseases
10/09/2014WO2014163518A1 Treatments involving eslicarbazepine or eslicarbazepine acetate
10/09/2014WO2014163512A1 Therapeutic compositions comprising extracts of propolis and uses thereof
10/09/2014WO2014163416A1 Composition for life extension containing (+)-syringaresinol
10/09/2014WO2014163400A1 Pharmaceutical composition for parenteral administration, containing donepezil
10/09/2014WO2014163278A1 Composition for protecting against radioactivity comprising fisetin compound as active ingredient
10/09/2014WO2014163219A1 Novel phytospingosine-1-phosphate derivative, preparation method therefor, and composition for preventing and treating hair loss or for growing hair comprising same
10/09/2014WO2014163215A1 Pharmaceutical composition having masked bitter taste
10/09/2014WO2014163210A1 [11 c] and [18f] labeled 1,3-diphenyl-5-(pyrimidin-2-yl)-pyridin-2(1 h)-one derivatives and their use for pet imaging of the ampa receptor
10/09/2014WO2014163178A1 Elastin synthesis/regeneration promoting agent
10/09/2014WO2014163162A1 Heterocyclic compound
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014163152A1 Non-rem sleep-promoting agent, deep sleep-promoting agent and natural sleep-inducing agent
10/09/2014WO2014163151A1 Yeast culture, and composition for internal application
10/09/2014WO2014163150A1 Composition for internal use
10/09/2014WO2014163147A1 Salt of pyrazoloquinoline derivative, and crystal thereof
10/09/2014WO2014163146A1 Pyridinylpyrazoloquinoline compound
10/09/2014WO2014163142A1 Ophthalmic composition
10/09/2014WO2014163132A1 Solid composition of amino carboxylate salt
10/09/2014WO2014163092A1 Drug coat layer, method for controlling morphological form of drug coat layer, and medical device
10/09/2014WO2014163031A1 Instantaneous intestinal regulator
10/09/2014WO2014163030A1 Preparation for treating equine inflammation
10/09/2014WO2014162737A1 Tau aggregation inhibitor
10/09/2014WO2014162515A1 Peritoneal dialysis fluid
10/09/2014WO2014162313A1 Anti-inflammatory synergistic combinations comprising omega-3 fatty acid and tomato lycopene
10/09/2014WO2014162303A1 Use of a dietary fibre supplement in a food formulation
10/09/2014WO2014162276A1 A composition for treating neuropathy, a process and a method of treatment thereof
10/09/2014WO2014162195A1 Two-component formulations, methods and procedures to prevent or reduce trauma-induced neuropathology and neurodegeneration
10/09/2014WO2014162126A1 Urea derivatives useful as kinase inhibitors
10/09/2014WO2014162124A1 Therapeutic uses of bisphosphonates
10/09/2014WO2014162123A1 Therapeutic uses of bisphosphonates
10/09/2014WO2014162122A1 Kinase inhibitor
10/09/2014WO2014162121A1 Kinase inhibitors based upon n-alkyl pyrazoles
10/09/2014WO2014162106A1 Novel chalcone derivatives having an anti-allergic activity
10/09/2014WO2014162039A1 Protein kinase inhibitors
10/09/2014WO2014162010A1 Barettin and derivatives thereof for medical use, in particular for the treatment of diseases related to oxidative stress or inflammation, and for preserving or washing organs
10/09/2014WO2014161960A1 Synthesis and use of isotopically-labelled glycans
10/09/2014WO2014161938A1 Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor
10/09/2014WO2014161919A1 Therapeutic uses of empagliflozin
10/09/2014WO2014161918A1 Therapeutic uses of empagliflozin
10/09/2014WO2014161891A1 Ingenol mebutate in combination with laser therapy for the treatment of hyperkeratotic skin lesions
10/09/2014WO2014161872A1 Compositions for use in stimulating bone growth
10/09/2014WO2014161836A1 Treatment of metabolic disorders in equine animals
10/09/2014WO2014161815A1 Glycogen-based water solubility enhancers
10/09/2014WO2014161808A1 Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]jpyridin-5-yl)-4- quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4- quinazolinamine derivatives as perk inhibitors
10/09/2014WO2014161801A1 Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one
10/09/2014WO2014161799A1 Inhibitors of bruton's tyrosine kinase
10/09/2014WO2014161595A1 Use of pidotimod to treat inflammatory bowel disease
10/09/2014WO2014161594A1 Use of pidotimod to treat irritable bowel syndrome
10/09/2014WO2014161516A1 Oxa- and thia-diazoles useful in the treatment of tuberculosis
10/09/2014WO2014161412A1 Tricyclic quinolone derivative and preparation method and use thereof
10/09/2014WO2014161131A1 PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS
10/09/2014WO2014161046A1 Methods of treating diseases characterized by excessive wnt signalling
10/09/2014WO2014113700A9 Pharmaceutical compositions comprising nitroxyl donors
10/09/2014WO2013102907A9 Ophthalmic composition
10/09/2014US20140303574 Adhesive patch assembly with overlay liner and system and method for making same
10/09/2014US20140303571 Titratable dosage transdermal delivery system
10/09/2014US20140303403 Chemically modified small molecules
10/09/2014US20140303260 Pharmaceutical compositions of resveratrol
10/09/2014US20140303259 Method for enhancing the bioavailability of ospemifene
10/09/2014US20140303258 Method of solubilizing insoluble bioactive compounds using triterpene glycosides and compositions thereof
10/09/2014US20140303257 Use of EDG Receptor Binding Agents in Cancer
10/09/2014US20140303256 Pharmaceutical composition comprising fluoxetine as an active ingredient for preventing or treating blood-brain disorders
10/09/2014US20140303254 Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
10/09/2014US20140303252 Osmotic drug delivery system
10/09/2014US20140303251 Methods Of Treating Acute Kidney Injury With Retinoic Acid
10/09/2014US20140303250 Pharmaceutical Solid Compositions Containing Ibuprofen Salts
10/09/2014US20140303249 Topical fungicidal agents for treating nail disorders
10/09/2014US20140303247 Membrane activated chelators and use in the prevention and treatment of parasitic infection
10/09/2014US20140303246 Use of adamantane derivatives for the treatment of actinic keratosis
10/09/2014US20140303245 Sustained Release Composition of Prostacyclin
10/09/2014US20140303244 Methods of treating cancer with herbacetin
10/09/2014US20140303242 Sparstolonin B Based Pharmaceutical Agent to Treat Pathological Angiogensis
10/09/2014US20140303239 Telomerase mediated telomere altering compounds
10/09/2014US20140303234 Methods for the modulation of angiogenesis
10/09/2014US20140303231 Methods and compositions for treating or preventing pruritis
10/09/2014US20140303227 Transmucosal hormone delivery system
10/09/2014US20140303226 Kcnq channels as therapeutic targets
10/09/2014US20140303225 Pharmaceutical composition for peroral administration of 3,3'-diindolylmethane
10/09/2014US20140303223 Composition and method for muscle repair and regeneration
10/09/2014US20140303222 Dual-acting imidazole antihypertensive agents
1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 7860